Suppr超能文献

通过满足监管需求确保个体化医学的有效开发:研究基础设施能发挥什么作用?

Ensuring efficient development of personalized medicine by addressing regulatory needs: What role can research infrastructures play?

机构信息

Istituto Superiore di Sanità, Rome, Italy.

EATRIS- European Research Infrastructure for Translational Medicine, Amsterdam, Netherlands.

出版信息

Int J Biol Markers. 2023 Jun;38(2):77-80. doi: 10.1177/03936155231179981. Epub 2023 Jun 5.

Abstract

Personalized Medicine is a novel medical practice that uses an individual's genetic profile to guide decisions made regarding the prevention, diagnosis, and treatment of disease. Knowledge of a patient's genetic profile is crucial to support doctors in selecting the proper therapy and administer it using the correct dose or regimen. Personalized Medicine is a great opportunity to turn the "one size fits all" approach to diagnostics, therapy, and prevention, into an individualized approach. In this paper we analyze the most recent achievements and regulatory challenges in Personalized Medicine and the role that research infrastructures can play in advancing its development.

摘要

个性化医疗是一种新颖的医疗实践,它利用个体的基因谱来指导预防、诊断和治疗疾病的决策。了解患者的基因谱对于支持医生选择适当的治疗方法并使用正确的剂量或方案进行治疗至关重要。个性化医疗为将“一刀切”的诊断、治疗和预防方法转变为个体化方法提供了绝佳机会。本文分析了个性化医疗的最新成果和监管挑战,以及研究基础设施在推动其发展方面可以发挥的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验